ccording to the latest report from the International Society of Aesthetic Plastic Surgery, breast implant augmentation was the most common plastic surgery operation worldwide in 2018, with almost 2 million procedures performed. 1 Among these, capsular contracture is the most commonly reported complication, with the highest morbidity and reintervention rate. [2][3][4] The prevalence of capsular contractures varies from 0.5 to 30 percent and depends on multiple factors, such as the type of implant; the type of surgery; preoperative, intraoperative, and postoperative surgical procedures; and other unidentified factors. 3,[5][6][7][8][9][10][11] Most breast implant studies have been oriented to determine and reduce the incidence of complications, specifically, capsular contracture. [12][13][14][15][16][17] Current research on textured implants suggested an association with the development of anaplastic large cell lymphoma. [18][19][20] As of September 22, 2020, the American Society of Plastic Surgeons confirmed 964 cases of breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL)

Therapeutic, II.